Computerized Cardiotocography and Fetal Heart Response to Maternal Coffee Intake: A Prospective Study

University of Campania "Luigi Vanvitelli"1 site in 1 country134 target enrollmentJuly 1, 2022

ConditionsPrenatal Care

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Prenatal Care
Sponsor: University of Campania "Luigi Vanvitelli"
Enrollment: 134
Locations: 1
Primary Endpoint: Computerized cardiotocography
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The study includes pregnant women referred for foetal antepartum computerized cardiotocography (cCTG) monitoring as outpatients. Pregnant women were divided into two groups based on their coffee intake: the coffee group and the control group. Each pregnant woman had cCTG. Two doctors assessed and recorded the amount of coffee taken by pregnant women before the CTG.

Registry

clinicaltrials.gov

Start Date

July 1, 2022

End Date

September 28, 2022

Last Updated

3 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

University of Campania "Luigi Vanvitelli"

Responsible Party

Principal Investigator

Marco La Verde

Researcher

University of Campania "Luigi Vanvitelli"

Eligibility Criteria

Inclusion Criteria

•gestationale age \>37 weeks

Exclusion Criteria

•fetal malformations,
•stillbirths
•preterm labour
•preterm and term premature rupture of membranes

Outcomes

Primary Outcomes

Computerized cardiotocography

Time Frame: 1 day (cardiotocographic's test)

Computerized cardiotocography (cCTG) parameters evaluate the fetal heart rate. We analyzed the cCTG between the two groups: pregnant who took coffee and pregnant with no coffee intake.